Search - tctmd.com

Displaying 1 - 20 of 70

Sort: Relevancy | Date

News Opinion Editor's Corner TCT 2016

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

Shelley Wood

November 07, 2016

Presentation TCT 2016

Double-edged Sealing Embolic Protection Device (Transverse)

Presenter: Eric Goslau

October 31, 2016

Presentation TCT 2016

Atherotomy, Atherectomy, and Embolic Protection

Presenter: Bonnie H. Weiner, Jose M. Wiley, Robert T. Pyo

October 29, 2016

News Opinion Editor's Corner TCT 2016

TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever

Shelley Wood

October 24, 2016

News Daily News

Vascular Solutions Recalls Twin-Pass Dual-Access Catheters

Michael O'Riordan

October 06, 2016

Presentation TVT 2016

The Case for and Against Cerebral Embolic Protection During TAVR

Presenter: Susheel Kodali

June 16, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2016

Shelley Wood

May 31, 2016

Presentation Fellows 2016

Thrombectomy, Embolic Protection Systems, and SVG Intervention

Presenter: Dimitrios Karmpaliotis, Manish A. Parikh

April 16, 2016

News Conference News ACC 2016

New-Generation Watchman FLX Device Pulled From European Shelves Over Embolism Concerns

Todd Neale

April 04, 2016

News Daily News

卒中率下降使人质疑是否有必要在 TAVR 中置入血栓预防设备

Michael O'Riordan

March 14, 2016

News Daily News

Bajan los Índices de ACV y Aumentan las Dudas sobre los Dispositivos de Protección Embólica en las Intervenciones TAVR

Michael O'Riordan

March 14, 2016

News Daily News

As Stroke Rates Fall, Questions Mount for Embolic Protection Devices in TAVR

Michael O'Riordan

March 14, 2016

News Conference News ISC 2016

ACT I, CREST Support Carotid Stenting as Alternative to Surgery, but Larger Question Looms

Todd Neale

February 17, 2016

News Conference News ISET 2016

‘Encouraging’ Early Findings With Embolic Protection in TEVAR, Suggests Small Pilot Study

Michael O'Riordan

February 08, 2016

News Industry News

ArtVentive Medical Begins Testing the Next Generation of its EOS™ Technology

December 02, 2015

News Industry News

InspireMD Receives EU Regulatory Approval for Additional Supplier of CGuard™ Delivery Catheters

December 01, 2015

News Industry News

Praxbind® (idarucizumab) approved in European Union for the specific reversal of Pradaxa® (dabigatran etexilate)

November 29, 2015

News Conference News TCT 2015

MISTRAL-C: Cerebral Protection in TAVR May Reduce New Lesions

October 14, 2015

News Industry News

First US Multi-center Study Finds Unprotected TAVR Procedures Produce New Brain Lesions in Nearly All Cases

October 14, 2015

News Industry News

InspireMD Announces Full Market Launch of CGuard™ Distributed by Penumbra at CIRSE Annual Congress

September 28, 2015

Advertisement

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

Double-edged Sealing Embolic Protection Device (Transverse)

Atherotomy, Atherectomy, and Embolic Protection

TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever

Vascular Solutions Recalls Twin-Pass Dual-Access Catheters

The Case for and Against Cerebral Embolic Protection During TAVR

TCTMD’s Top 10 Most Popular Stories for May 2016

Thrombectomy, Embolic Protection Systems, and SVG Intervention

New-Generation Watchman FLX Device Pulled From European Shelves Over Embolism Concerns

卒中率下降使人质疑是否有必要在 TAVR 中置入血栓预防设备

Bajan los Índices de ACV y Aumentan las Dudas sobre los Dispositivos de Protección Embólica en las Intervenciones TAVR

As Stroke Rates Fall, Questions Mount for Embolic Protection Devices in TAVR

ACT I, CREST Support Carotid Stenting as Alternative to Surgery, but Larger Question Looms

‘Encouraging’ Early Findings With Embolic Protection in TEVAR, Suggests Small Pilot Study

ArtVentive Medical Begins Testing the Next Generation of its EOS™ Technology

InspireMD Receives EU Regulatory Approval for Additional Supplier of CGuard™ Delivery Catheters

Praxbind® (idarucizumab) approved in European Union for the specific reversal of Pradaxa® (dabigatran etexilate)

MISTRAL-C: Cerebral Protection in TAVR May Reduce New Lesions

First US Multi-center Study Finds Unprotected TAVR Procedures Produce New Brain Lesions in Nearly All Cases

InspireMD Announces Full Market Launch of CGuard™ Distributed by Penumbra at CIRSE Annual Congress

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content